These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 31676442)
81. Antiobesity drug-likeness properties and pancreatic lipase inhibition of a novel low molecular weight lutein oxidized product, LOP6. Shamarao N; Chethankumar M Food Funct; 2022 Jun; 13(11):6036-6055. PubMed ID: 35615990 [TBL] [Abstract][Full Text] [Related]
82. Characterization of novel PNLIP variants in congenital pancreatic lipase deficiency. Lin J; Matiwala N; Curry GE; Wilhelm SJ; Cassidy BM; Lowe ME; Xiao X Pancreatology; 2023 Dec; 23(8):1036-1040. PubMed ID: 37926600 [TBL] [Abstract][Full Text] [Related]
83. Identification of a novel mutation in the PNLIP gene in two brothers with congenital pancreatic lipase deficiency. Behar DM; Basel-Vanagaite L; Glaser F; Kaplan M; Tzur S; Magal N; Eidlitz-Markus T; Haimi-Cohen Y; Sarig G; Bormans C; Shohat M; Zeharia A J Lipid Res; 2014 Feb; 55(2):307-12. PubMed ID: 24262094 [TBL] [Abstract][Full Text] [Related]
84. Lipase Inhibitors for Obesity: A Review. Liu TT; Liu XT; Chen QX; Shi Y Biomed Pharmacother; 2020 Aug; 128():110314. PubMed ID: 32485574 [TBL] [Abstract][Full Text] [Related]
85. Drug-guided screening for pancreatic lipase inhibitors in functional foods. Zhang L; Zheng J; Ma M; Zhao Y; Song J; Chen X; Cao W; He X; Xue C; Tang Q Food Funct; 2021 May; 12(10):4644-4653. PubMed ID: 33912875 [TBL] [Abstract][Full Text] [Related]
86. Exploring the enigmatic association between PNLIP variants and risk of chronic pancreatitis in a large Chinese cohort. Cassidy BM; Jiang F; Lin J; Chen JM; Curry GE; Ma GX; Wilhelm SJ; Deng SJ; Zhu G; Liao Z; Lowe ME; Xiao XK; Zou WB Pancreatology; 2024 Jun; 24(4):511-521. PubMed ID: 38485544 [TBL] [Abstract][Full Text] [Related]
87. Synthesis, molecular modelling, S N C S; Sengupta P; Palawat S; P S D; George G; Paul AT J Biomol Struct Dyn; 2022; 40(19):9530-9542. PubMed ID: 34032197 [TBL] [Abstract][Full Text] [Related]
88. Inhibitory effect of a weight-loss Chinese herbal formula RCM-107 on pancreatic α-amylase activity: Enzymatic and in silico approaches. Luo S; Lenon GB; Gill H; Hung A; Dias DA; Li M; Nguyen LT PLoS One; 2020; 15(4):e0231815. PubMed ID: 32348327 [TBL] [Abstract][Full Text] [Related]
89. Identification of protease-sensitive but not misfolding PNLIP variants in familial and hereditary pancreatitis. Masson E; Berthet S; Le Gac G; Le Rhun M; Ka C; Autret S; Gourlaouen I; ; Cooper DN; Férec C; Rebours V; Chen JM Pancreatology; 2023 Aug; 23(5):507-511. PubMed ID: 37270400 [TBL] [Abstract][Full Text] [Related]
90. Novel homozygous mutation of PNLIP gene in congenital pancreatic lipase deficiency: an extended family study. Kamal NM; Saadah OI; Alheraiti SS; Attar R; Alsufyani AD; El-Shabrawi MHF; Sherief LM Ther Adv Chronic Dis; 2022; 13():20406223221078757. PubMed ID: 35284057 [TBL] [Abstract][Full Text] [Related]
91. Effects of surfactants on lipase structure, activity, and inhibition. Delorme V; Dhouib R; Canaan S; Fotiadu F; Carrière F; Cavalier JF Pharm Res; 2011 Aug; 28(8):1831-42. PubMed ID: 21234659 [TBL] [Abstract][Full Text] [Related]
92. Behavior of tetrahydrolipstatin in biological model membranes and emulsions. Ko J; Small DM J Lipid Res; 1997 Aug; 38(8):1544-52. PubMed ID: 9300776 [TBL] [Abstract][Full Text] [Related]
93. In vitro anti-obesity activity by pancreatic lipase inhibition - Simple HPLC approach using EVOO as natural substrate. Blasi F; Ianni F; Mangiapelo L; Pinna N; Cossignani L J Sci Food Agric; 2023 Apr; 103(6):2786-2793. PubMed ID: 36583522 [TBL] [Abstract][Full Text] [Related]
94. Pancreatic lipase inhibitory activity of taraxacum officinale in vitro and in vivo. Zhang J; Kang MJ; Kim MJ; Kim ME; Song JH; Lee YM; Kim JI Nutr Res Pract; 2008; 2(4):200-3. PubMed ID: 20016719 [TBL] [Abstract][Full Text] [Related]
95. Crystal structure of pathogenic Staphylococcus aureus lipase complex with the anti-obesity drug orlistat. Kitadokoro K; Tanaka M; Hikima T; Okuno Y; Yamamoto M; Kamitani S Sci Rep; 2020 Mar; 10(1):5469. PubMed ID: 32214208 [TBL] [Abstract][Full Text] [Related]
96. The discovery of the natural compound Boeravinone-C as a potential antiobesity drug candidate targeting pancreatic lipase using chemo-informatics-based approaches. Unnisa A; Anwar S; Ananda K C; Khalifa NE; Khojali WMA; Osman ME; M Younes K; S Abouzied A; Jandrajupalli SB; Chandolu S Cell Mol Biol (Noisy-le-grand); 2023 Jul; 69(7):57-65. PubMed ID: 37715427 [TBL] [Abstract][Full Text] [Related]
97. Structure and Function of Pancreatic Lipase-Related Protein 2 and Its Relationship With Pathological States. Zhu G; Fang Q; Zhu F; Huang D; Yang C Front Genet; 2021; 12():693538. PubMed ID: 34290745 [TBL] [Abstract][Full Text] [Related]
98. Construction and Manipulation of Serial Gradient Dilution Array on a Microfluidic Slipchip for Screening and Characterizing Inhibitors against Human Pancreatic Lipase. Yang J; Deng Y; Zhang M; Feng S; Peng S; Yang S; Liu P; Cai G; Ge G Biosensors (Basel); 2023 Feb; 13(2):. PubMed ID: 36832040 [TBL] [Abstract][Full Text] [Related]
99. The inhibitory effects of an eight-herb formula (RCM-107) on pancreatic lipase: enzymatic, Luo S; Gill H; Dias DA; Li M; Hung A; Nguyen LT; Lenon GB Heliyon; 2019 Sep; 5(9):e02453. PubMed ID: 31538117 [TBL] [Abstract][Full Text] [Related]
100. Inhibitors of pancreatic lipase: state of the art and clinical perspectives. Lunagariya NA; Patel NK; Jagtap SC; Bhutani KK EXCLI J; 2014; 13():897-921. PubMed ID: 26417311 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]